1652 related articles for article (PubMed ID: 28587163)
1. A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.
Parfett CL; Desaulniers D
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587163
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
3. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis.
Recillas-Targa F; De La Rosa-Velázquez IA; Soto-Reyes E; Benítez-Bribiesca L
J Cell Mol Med; 2006; 10(3):554-68. PubMed ID: 16989720
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
7. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1.
Zhang C; Su ZY; Wang L; Shu L; Yang Y; Guo Y; Pung D; Bountra C; Kong AN
Biochem Pharmacol; 2016 Oct; 117():35-45. PubMed ID: 27520485
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic alterations in cancer.
Ilango S; Paital B; Jayachandran P; Padma PR; Nirmaladevi R
Front Biosci (Landmark Ed); 2020 Mar; 25(6):1058-1109. PubMed ID: 32114424
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review.
Chappell G; Pogribny IP; Guyton KZ; Rusyn I
Mutat Res Rev Mutat Res; 2016; 768():27-45. PubMed ID: 27234561
[TBL] [Abstract][Full Text] [Related]
11. Interplay between different epigenetic modifications and mechanisms.
Murr R
Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
[TBL] [Abstract][Full Text] [Related]
12. Predicting Carcinogenic Mechanisms of Non-Genotoxic Carcinogens via Combined Analysis of Global DNA Methylation and In Vitro Cell Transformation.
Hwang SH; Yeom H; Han BI; Ham BJ; Lee YM; Han MR; Lee M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751172
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells.
Ji W; Yang L; Yu L; Yuan J; Hu D; Zhang W; Yang J; Pang Y; Li W; Lu J; Fu J; Chen J; Lin Z; Chen W; Zhuang Z
Carcinogenesis; 2008 Jun; 29(6):1267-75. PubMed ID: 18204074
[TBL] [Abstract][Full Text] [Related]
14. Current Insights into Oral Cancer Epigenetics.
Irimie AI; Ciocan C; Gulei D; Mehterov N; Atanasov AG; Dudea D; Berindan-Neagoe I
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495520
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic events during the process of cell transformation induced by carcinogens (review).
Nguyen-Ba G; Vasseur P
Oncol Rep; 1999; 6(4):925-32. PubMed ID: 10373683
[TBL] [Abstract][Full Text] [Related]
16. Epigenome dysregulation in cholangiocarcinoma.
O'Rourke CJ; Munoz-Garrido P; Aguayo EL; Andersen JB
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1423-1434. PubMed ID: 28645654
[TBL] [Abstract][Full Text] [Related]
17. Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer.
Alhosin M; Omran Z; Zamzami MA; Al-Malki AL; Choudhry H; Mousli M; Bronner C
J Exp Clin Cancer Res; 2016 Nov; 35(1):174. PubMed ID: 27839516
[TBL] [Abstract][Full Text] [Related]
18. The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation.
Gasque Schoof CR; Izzotti A; Jasiulionis MG; Vasques Ldos R
Biomed Res Int; 2015; 2015():634749. PubMed ID: 26618174
[TBL] [Abstract][Full Text] [Related]
19. In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis.
Kleinstreuer NC; Dix DJ; Houck KA; Kavlock RJ; Knudsen TB; Martin MT; Paul KB; Reif DM; Crofton KM; Hamilton K; Hunter R; Shah I; Judson RS
Toxicol Sci; 2013 Jan; 131(1):40-55. PubMed ID: 23024176
[TBL] [Abstract][Full Text] [Related]
20. Toxicogenomics applied to in vitro carcinogenicity testing with Balb/c 3T3 cells revealed a gene signature predictive of chemical carcinogens.
Rohrbeck A; Salinas G; Maaser K; Linge J; Salovaara S; Corvi R; Borlak J
Toxicol Sci; 2010 Nov; 118(1):31-41. PubMed ID: 20713471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
